Bellerophon Therapeutics (BLPH) Reports Q3 Loss of $0.37/Share

Bellerophon Therapeutics (NASDAQ: BLPH) reported Q3 EPS of ($0.37), versus ($0.83) reported last year.

For earnings history and earnings-related data on Bellerophon Therapeutics (BLPH) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• UBS says bull market has further to run
• Intchains Group Ltd (ICG) PT Lowered to $2 at Benchmark Following 1H Results